Risk factor
Poor trading liquidity
Profitability factor
Undervalued vs peers
About
Duopharma Biotech Berhad, an investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally. The company offers consumer healthcare products comprising vitamins and supplements, analgesics, eyecare, antacids, and skin care products; and generic drugs for various therapeutic classes, such as cardiovascular, dermatology, hormones, respiratory, sensory and nervous system,...
Company Valuation
Based on key historical and expected multiples, the stock is undervalued relative to its peers. Specifically, the stock is 'cheap' on P/E, neutral on EV/EBITDA, underpric
Target Price
The average target price of 7148.KL is 1.7 and suggests 25% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell